Group | Descriptive statistics Mean (SD) | Change at 15 months: Within-group p-value | Change at 15 months: Between groups | ||||
---|---|---|---|---|---|---|---|
Workshop | Final | Adjusted mean (SE) | 95% CI | Between-group p-value | |||
HbA1c*,% | I (n = 73) | 7.12 (0.42) | 7.09 (0.41) | 0.34 | 0.02 (0.04) | (−0.05 to 0.09) | 0.63 |
C (n = 76) | 7.20 (0.52) | 7.15 (0.51) | 0.13 | ||||
% patients HbA1c ≤ 7.0% | I (n = 73) | 58.40 (16.20) | 58.68 (15.40) | 0.76 | −1.22 (1.30) | (−3.78 to 1.35) | 0.35 |
C (n = 76) | 55.95 (15.65) | 57.58 (16.12) | 0.15 | ||||
FPG† level in mmol/L | I (n = 71) | 7.86 (0.67) | 7.78 (0.68) | 0.13 | 0.01 (0.07) | (−0.13 to 0.15) | 0.85 |
C (n = 70) | 7.89 (0.69) | 7.82 (0.68) | 0.22 | ||||
% patients prescribed OAD‡ | I (n = 73) | 80.87 (10.83) | 83.32 (9.98) | < 0.001 | 0.87 (0.65) | (−0.42 to 2.16) | 0.18 |
C (n = 76) | 79.24 (12.06) | 81.12 (11.14) | < 0.001 | ||||
OAD score§ | I (n = 73) | 1.32 (0.20) | 1.37 (0.21) | < 0.001 | 0.01 (0.02) | (−0.03 to 0.04) | 0.65 |
C (n = 76) | 1.38 (0.21) | 1.41 (0.24) | 0.02 | ||||
% patients prescribed insulin | I (n = 73) | 11.53 (8.93) | 17.14 (10.64) | < 0.001 | −1.06 (0.88) | (−2.80 to 0.69) | 0.23 |
C (n = 76) | 11.53 (8.51) | 18.38 (10.82) | < 0.001 | ||||
Insulin daily dose (units) | I (n = 61) | 47.91 (21.24) | 53.64 (22.71) | < 0.01 | 5.96 (2.83) | (0.35 to 11.56) | 0.04 |
C (n = 57) | 57.19 (26.21) | 54.94 (23.65) | 0.30 | ||||
Intensification of diabetes management** | I (n = 73) | -- | 31.59 (14.17) | -- | −0.29 (2.35) | (−4.93 to 4.34) | 0.90 |
C (n = 76) | -- | 32.80 (14.91) | -- |